322 related articles for article (PubMed ID: 25030535)
1. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
[TBL] [Abstract][Full Text] [Related]
2. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
4. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
[TBL] [Abstract][Full Text] [Related]
5. Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.
Nicholls SJ; Tuzcu EM; Wolski K; Bayturan O; Lavoie A; Uno K; Kupfer S; Perez A; Nesto R; Nissen SE
J Am Coll Cardiol; 2011 Jan; 57(2):153-9. PubMed ID: 21211686
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
7. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
[TBL] [Abstract][Full Text] [Related]
8. Atheroma progression in hyporesponders to statin therapy.
Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
[TBL] [Abstract][Full Text] [Related]
9. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
[TBL] [Abstract][Full Text] [Related]
10. Relation of change in apolipoprotein B/apolipoprotein A-I ratio to coronary plaque regression after Pravastatin treatment in patients with coronary artery disease.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Am J Cardiol; 2010 Jan; 105(2):144-8. PubMed ID: 20102908
[TBL] [Abstract][Full Text] [Related]
11. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
Nissen SE; Tsunoda T; Tuzcu EM; Schoenhagen P; Cooper CJ; Yasin M; Eaton GM; Lauer MA; Sheldon WS; Grines CL; Halpern S; Crowe T; Blankenship JC; Kerensky R
JAMA; 2003 Nov; 290(17):2292-300. PubMed ID: 14600188
[TBL] [Abstract][Full Text] [Related]
13. Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease.
Elshazly MB; Mani P; Nissen S; Brennan DM; Clark D; Martin S; Jones SR; Quispe R; Donnellan E; Nicholls SJ; Puri R
Eur J Prev Cardiol; 2020 Jul; 27(10):1091-1100. PubMed ID: 31744333
[TBL] [Abstract][Full Text] [Related]
14. Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.
Nicholls SJ; Andrews J; Kastelein JJP; Merkely B; Nissen SE; Ray KK; Schwartz GG; Worthley SG; Keyserling C; Dasseux JL; Griffith L; Kim SW; Janssan A; Di Giovanni G; Pisaniello AD; Scherer DJ; Psaltis PJ; Butters J
JAMA Cardiol; 2018 Sep; 3(9):815-822. PubMed ID: 30046828
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
[TBL] [Abstract][Full Text] [Related]
16. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
17. Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN.
Stegman B; Shao M; Nicholls SJ; Elshazly M; Cho L; King P; Kapadia S; Tuzcu M; Nissen SE; Puri R
Atherosclerosis; 2016 Nov; 254():78-84. PubMed ID: 27710808
[TBL] [Abstract][Full Text] [Related]
18. Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Terashima M; Michishita I;
Coron Artery Dis; 2012 Jun; 23(4):239-44. PubMed ID: 22441135
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.
Nicholls SJ; Gordon A; Johansson J; Wolski K; Ballantyne CM; Kastelein JJ; Taylor A; Borgman M; Nissen SE
J Am Coll Cardiol; 2011 Mar; 57(9):1111-9. PubMed ID: 21255957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
